| Primary |
| Glaucoma |
57.5% |
| Hypertension |
8.9% |
| Intraocular Pressure Increased |
8.2% |
| Open Angle Glaucoma |
4.5% |
| Diabetes Mellitus |
2.5% |
| Blood Cholesterol Increased |
2.4% |
| Ocular Hypertension |
1.9% |
| Intraocular Pressure Test |
1.5% |
| Ill-defined Disorder |
1.4% |
| Thyroid Disorder |
1.4% |
| Cardiac Disorder |
1.3% |
| Cataract |
1.2% |
| Intraocular Pressure Test Abnormal |
1.1% |
| Osteoporosis |
1.0% |
| Arthritis |
0.9% |
| Normal Tension Glaucoma |
0.9% |
| Blood Pressure |
0.9% |
| Blood Cholesterol |
0.8% |
| Hypothyroidism |
0.8% |
| Prophylaxis |
0.8% |
|
| Intraocular Pressure Increased |
19.7% |
| Visual Acuity Reduced |
9.6% |
| Ocular Hyperaemia |
8.1% |
| Death |
7.8% |
| Eye Irritation |
7.7% |
| Vision Blurred |
6.5% |
| Cataract |
6.4% |
| Visual Impairment |
4.7% |
| Glaucoma |
4.1% |
| Eye Pain |
4.0% |
| Eye Disorder |
3.7% |
| Drug Ineffective |
3.1% |
| Cataract Operation |
2.2% |
| Hypertension |
2.2% |
| Product Quality Issue |
2.2% |
| Dry Eye |
1.7% |
| Weight Decreased |
1.6% |
| Headache |
1.6% |
| Visual Field Defect |
1.6% |
| Hypersensitivity |
1.5% |
|
| Secondary |
| Glaucoma |
38.0% |
| Intraocular Pressure Increased |
11.8% |
| Hypertension |
9.7% |
| Product Used For Unknown Indication |
5.9% |
| Drug Use For Unknown Indication |
4.9% |
| Open Angle Glaucoma |
4.1% |
| Blood Cholesterol Increased |
3.3% |
| Ocular Hypertension |
3.0% |
| Cardiac Disorder |
2.5% |
| Cataract |
2.4% |
| Diabetes Mellitus |
2.1% |
| Thyroid Disorder |
1.7% |
| Ill-defined Disorder |
1.7% |
| Intraocular Pressure Test |
1.4% |
| Gastritis |
1.3% |
| Macular Degeneration |
1.3% |
| Prophylaxis |
1.3% |
| Hypothyroidism |
1.2% |
| Cerebral Infarction |
1.1% |
| Eye Disorder |
1.0% |
|
| Intraocular Pressure Increased |
18.8% |
| Visual Acuity Reduced |
9.6% |
| Ocular Hyperaemia |
7.1% |
| Eye Irritation |
6.7% |
| Vision Blurred |
6.5% |
| Vomiting |
5.8% |
| Glaucoma |
4.7% |
| Visual Impairment |
4.7% |
| Death |
4.0% |
| Drug Ineffective |
3.8% |
| Eye Disorder |
3.6% |
| Weight Decreased |
3.3% |
| Tinnitus |
3.1% |
| Hypersensitivity |
2.9% |
| Off Label Use |
2.9% |
| Pain In Extremity |
2.9% |
| Thyroid Cancer |
2.7% |
| Cataract |
2.5% |
| Eye Pain |
2.2% |
| Product Quality Issue |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.3% |
| Drug Use For Unknown Indication |
17.8% |
| Glaucoma |
15.9% |
| Hypertension |
10.0% |
| Pain |
3.5% |
| Prophylaxis |
3.1% |
| Diabetes Mellitus |
3.0% |
| Osteoporosis |
2.9% |
| Atrial Fibrillation |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Blood Cholesterol Increased |
2.4% |
| Asthma |
2.1% |
| Depression |
2.0% |
| Type 2 Diabetes Mellitus |
1.9% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Non-small Cell Lung Cancer |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Arthritis |
1.3% |
| Multiple Myeloma |
1.3% |
| Nausea |
1.2% |
|
| Vomiting |
13.7% |
| Vision Blurred |
8.4% |
| Weight Decreased |
8.0% |
| Pneumonia |
6.0% |
| Visual Acuity Reduced |
5.7% |
| Weight Increased |
5.3% |
| Renal Failure Acute |
4.8% |
| Dyspnoea |
4.5% |
| Drug Ineffective |
4.3% |
| Nausea |
4.1% |
| Rash |
4.1% |
| Death |
4.0% |
| Somnolence |
3.6% |
| Tremor |
3.6% |
| Pain |
3.5% |
| Pyrexia |
3.5% |
| Wheezing |
3.5% |
| Pain In Extremity |
3.2% |
| Oedema Peripheral |
3.1% |
| Dizziness |
3.0% |
|
| Interacting |
| Glaucoma |
27.0% |
| Cataract Operation |
10.8% |
| Periodontitis |
10.8% |
| Back Pain |
8.1% |
| Hypoaesthesia |
8.1% |
| Arrhythmia |
5.4% |
| Diabetes Mellitus |
5.4% |
| Hypertension |
5.4% |
| Myocardial Ischaemia |
5.4% |
| Product Used For Unknown Indication |
5.4% |
| Nerve Injury |
2.7% |
| Neuropathy Peripheral |
2.7% |
| Pain |
2.7% |
|
| Tooth Disorder |
27.3% |
| Drug Interaction |
18.2% |
| Iritis |
9.1% |
| Nocturia |
9.1% |
| Pain |
9.1% |
| Periodontitis |
9.1% |
| Somnolence |
9.1% |
| Visual Acuity Reduced |
9.1% |
|
